Rhythm Pharmaceuticals
This role involves leading regulatory CMC strategies for biopharmaceutical programs targeting rare diseases, ensuring compliance and effective management of regulatory documents throughout product development and lifecycle. The position requires collaboration with internal teams and regulatory agencies to support the development, approval, and post-market activities of innovative therapies.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
8% above the average for this role
Senior Manager, Regulatory Affairs – CMC
Cytokinetics
Director, Regulatory CMC
Genetix Biotherapeutics
Global CMC Regulatory Affairs Lead
wattonhall
Global Regulatory Affairs (CMC) Manager
Integrated Resources INC
Regulatory Affairs CMC Professional
gloorlang
Senior Regulatory CMC Strategist (Senior Director)
C0003153479P